Shunho 2023 Annual Performance: Revenue Increase and Yilong Brand Expansion

Business by 2FIRSTS.ai
Apr.30.2024
Shunho 2023 Annual Performance: Revenue Increase and Yilong Brand Expansion
Shunho Share releases annual report: 2023 revenue up 1.01% to 1.425 billion yuan, net profit up 147.41% to 28.4 million yuan.

On April 30th, Shunho Co., Ltd. (SZ002565) released its annual performance report, stating that its operating income in 2023 was approximately 1.425 billion yuan, an increase of 1.01% year-on-year. The net profit attributable to shareholders of the listed company was approximately 28.4 million yuan, an increase of 147.41% year-on-year.

Shunho 2023 Annual Performance: Revenue Increase and Yilong Brand Expansion
2023 Annual Report | Image Source: Shunho Corporation

 

Shunho Group has announced that its subsidiary Shunho Yilong holds the rights for the pod brand (domestic sales), e-cigarette accessories brand (domestic sales), and the combination of pod and smoking accessories brand sales (domestic sales). The brand is named "Yilong". During the reporting period, the "Yilong" brand e-cigarette products from Shunho Yilong have successfully launched in some retail stores in Beijing, Shenzhen, and Shanghai. The company plans to continue promoting the "Yilong" products in more regions in the future.

 

As of now, the subsidiary Green New Peak has obtained the Tobacco Wholesale Production Enterprise License for the e-cigarette processing enterprise. The participating company Mei Zhong Lian has obtained the Tobacco Wholesale Production Enterprise License for the e-cigarette production enterprise. The company's subsidiary Shunho Yilong has obtained the Tobacco Wholesale Production Enterprise License for the e-cigarette brand holding enterprise for domestic sales.

 

Shunho Corporation stated that, while ensuring the steady development of its environmentally friendly packaging new materials and printing businesses, the company is actively researching and developing new types of tobacco compliance products in accordance with policy requirements. It is also concentrating resources on applying for e-cigarette licenses and continuously conducting research and development investments in industrial hemp new technologies, new products, and overall plant applications. This has enabled the company to transition from a single manufacturing industry to a diversified, multi-industry chain expansion, achieving a new development pattern.

 

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

2Firsts Product Observation (8.25-8.29): UK Market Focuses on Pod Innovation, Multiple Brands Compete for Differentiation
2Firsts Product Observation (8.25-8.29): UK Market Focuses on Pod Innovation, Multiple Brands Compete for Differentiation
Recently, the UK e-cigarette market has displayed two distinct trends. First, the number of new product releases has slowed, with a notable decline in MHRA approvals. Second, innovation in product differentiation has accelerated, as seen with new launches from VOZOL and SKE. Additionally, ELFBAR has introduced limited-edition products, and OXBAR has focused on functional innovations, both contributing to a growing emphasis on differentiation.
Sep.01 by 2FIRSTS.ai
 Indonesian National Narcotics Agency Seizes New Type of Drug E-Cigarettes: Involves Synthetic Cannabis and Ketamine
Indonesian National Narcotics Agency Seizes New Type of Drug E-Cigarettes: Involves Synthetic Cannabis and Ketamine
The Indonesian National Narcotics Agency (BNN) recently intercepted a new type of drug disguised as e-cigarettes, including synthetic cannabis smuggled from Malaysia and ketamine from France. The authorities are calling for stricter regulations to protect the public.
Aug.25 by 2FIRSTS.ai
Philip Morris International U.S. White Paper: Misconceptions About Nicotine Among Medical Professionals, FDA Urged to Strengthen Public Education on “Smoke-Free Alternatives”
Philip Morris International U.S. White Paper: Misconceptions About Nicotine Among Medical Professionals, FDA Urged to Strengthen Public Education on “Smoke-Free Alternatives”
Philip Morris International’s U.S. affiliate (PMI America) has released a new white paper stating that U.S. healthcare professionals hold serious misconceptions about smoke-free products, with nearly half incorrectly believing that nicotine causes cancer. As a result, smokers are being denied scientifically accurate harm-reduction advice. The report calls on the U.S. Food and Drug Administration (FDA) to deliver accurate information on smoke-free alternatives to physicians, so they can help adul
Aug.19 by 2FIRSTS.ai
Cigar Sense Inc. Announces Research in Cigars to Connect Consumer Expectations, Experiences, and Authentic Brand Storytelling
Cigar Sense Inc. Announces Research in Cigars to Connect Consumer Expectations, Experiences, and Authentic Brand Storytelling
Independent research initiative highlights consumer truth as the new driver of loyalty and meaningful differentiation.
Sep.23
Mylor Innovation Lab Launches JuiSour Series: Revolutionizing Sour Aroma, Sour-Sweet Balance, and Juiciness in E-Liquids
Mylor Innovation Lab Launches JuiSour Series: Revolutionizing Sour Aroma, Sour-Sweet Balance, and Juiciness in E-Liquids
Mylor Innovation Lab will unveil its JuiSour Series at InterTabac in Dortmund, positioned around “aroma burst, sour-sweet balance,enhanced juiciness.” The new line comprises three sub-series — Berry, Candy, and Citrus — breaking through the limitations of traditional acetic acid and introducing the concept of a “Golden Sour-Sweet Ratio” to elevate the sour-aromatic profile and mouthfeel of e-liquids.
Sep.12
Imperial Tobacco Canada: Ban on ZONNIC Nicotine Pouches in Convenience Stores Leads to Cigarette Sales Rebound, Calls for Restoring Multi-Channel Supply
Imperial Tobacco Canada: Ban on ZONNIC Nicotine Pouches in Convenience Stores Leads to Cigarette Sales Rebound, Calls for Restoring Multi-Channel Supply
Imperial Tobacco Canada stated that one year ago, the government removed the nicotine pouch ZONNIC from convenience stores, restricting sales to behind-the-counter in pharmacies. This move caused ZONNIC sales to plummet, cigarette sales to rebound by 2.8%, and was accompanied by a surge of high-dose illegal nicotine pouches and black-market cigarettes (exceeding 500 million packs annually). The company is calling for an evidence-based harm reduction approach to restore multi-channel supply throu
Aug.20 by 2FIRSTS.ai